High-risk prescribing increases rates of new persistent opioid use in total hip arthroplasty patients
Journal of Arthroplasty Apr 20, 2020
Delaney LD, Gunaseelan V, Rieck H, et al. - Via conducting a retrospective analysis of Medicare claims in Michigan, researchers explored the connection between surgeon prescribing and new persistent use among total hip arthroplasty (THA) individuals. The study cohort comprised of orthopedic surgeons performing THAs from 2013-2016, and their opioid naïve patients, ages > 65. High-risk prescribing involved: high regular doses, overlapping prescriptions for benzodiazepine, concurrent opioid prescriptions, multi-provider prescriptions, or long-acting opioid prescriptions. Surgeons showed high-risk prescribing for 66% of encounters. The development of persistent opioid use after surgery is multifactorial, and the prescribing patterns of the surgeon play an important role. Reducing prescribing and encouraging opioid alternatives may reduce the persistent use of postoperative opioids.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries